Previous 10 |
Additionally, AIT to garner a 15%-20% royalty on gross profit AIT will immediately request to be listed on the NASDAQ stock exchange PMA submission on track for the second quarter of 2019 Company to host a call today, Thursday, January 24, 2019 at 8:30am ET GARDEN CITY, N.Y...
News, Short Squeeze, Breakout and More Instantly...
AIT Therapeutics Inc Company Name:
AITB Stock Symbol:
OTCMKTS Market:
Announces name change to Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar 2020 Announced licensing agreement ...
Announces name change to Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar 2020 Announced licensing agreeme...
GARDEN CITY, N.Y. and REHOVOT, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including s...